Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

216
Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
216
Peptidoglycan Synthesis01:28

Peptidoglycan Synthesis

4.8K
Structure of PeptidoglycanPeptidoglycan is a vital structural component of the bacterial cell wall, providing mechanical strength and shape to the cell. It consists of repeating units of two sugars—N-acetylglucosamine (NAG) and N-acetylmuramic acid (NAM)—linked by β-1,4 glycosidic bonds. These sugar chains are cross-linked by short peptide chains, forming a mesh-like polymer that surrounds the bacterial plasma membrane.Cytoplasmic Phase – Precursor SynthesisPeptidoglycan...
4.8K
Production of Pharmaceuticals01:30

Production of Pharmaceuticals

99
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under...
99
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

127
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
127
Biosynthesis in Bacteria01:24

Biosynthesis in Bacteria

1.0K
Biosynthesis in bacteria is a fundamental anabolic process that generates essential macromolecules, including proteins, nucleic acids, lipids, and polysaccharides. These macromolecules are critical for cellular growth, replication, and function. The process is tightly regulated and energetically linked to catabolic pathways to ensure optimal resource utilization.Biosynthetic pathways begin with precursor metabolites such as pyruvate, acetyl-CoA, and glucose-6-phosphate derived from glycolysis,...
1.0K
Production of Antibiotics01:27

Production of Antibiotics

281
Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
281

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A natural depsipeptide antibiotic binds the E-site of the bacterial ribosome.

Nature·2026
Same author

Ngt-1: A glycosyltransferase that confers resistance to three distinct antibiotic classes.

The Journal of biological chemistry·2026
Same author

Evaluation of the Seegene Novaplex<sup>TM</sup> dermatophyte assay for diagnosis of onychomycosis.

Diagnostic microbiology and infectious disease·2026
Same author

An Acetyltransferase Conferring Self-Resistance of the Producer to Lasso Peptide Antibiotic Lariocidin.

ACS infectious diseases·2026
Same author

Butyrolactol A enhances caspofungin efficacy via flippase inhibition in drug-resistant fungi.

Cell·2026
Same author

The Histidine Kinase VraS Interacts with Vancomycin and Penicillins Through its Membrane-Anchored N-terminal Domain.

Angewandte Chemie (International ed. in English)·2025
Same journal

Activation of hamiformamide production in the thermotolerant fungus Hamigera avellanea triggered by co-culture with animal immune cells.

The Journal of antibiotics·2026
Same journal

Biosynthesis and enzymology of azaindane natural products.

The Journal of antibiotics·2026
Same journal

Inhibition of Proteus mirabilis growth through gallium-based disruption of iron and heme metabolism.

The Journal of antibiotics·2026
Same journal

Artificial intelligence-based phenotypic screening using Aspergillus oryzae identified a novel antifungal RK-1205-I.

The Journal of antibiotics·2026
Same journal

Catenulamide A, an acylated tripeptide containing 5-methoxy-L-kynurenine lactam from an actinomycete of the genus Catenuloplanes.

The Journal of antibiotics·2026
Same journal

Longispora agrisoli sp. nov., a novel actinomycete isolated from soil of sweet potato field and producing γ-L-glutamyl-L-tryptophan.

The Journal of antibiotics·2026
See all related articles

Related Experiment Video

Updated: May 6, 2026

Synthesis of Masarimycin, a Small Molecule Inhibitor of Gram-Positive Bacterial Growth
09:10

Synthesis of Masarimycin, a Small Molecule Inhibitor of Gram-Positive Bacterial Growth

Published on: January 7, 2022

1.8K

Glycopeptide antibiotic biosynthesis.

Grace Yim1, Maulik N Thaker1, Kalinka Koteva1

  • 1MG DeGroote Institute for Infectious Disease Research, Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Ontario, Canada.

The Journal of Antibiotics
|November 14, 2013
PubMed
Summary
This summary is machine-generated.

Glycopeptide antibiotics are crucial for treating Gram-positive bacterial infections. Understanding their biosynthesis and resistance mechanisms is key to developing new antimicrobial drugs.

More Related Videos

From a Natural Product to Its Biosynthetic Gene Cluster: A Demonstration Using Polyketomycin from Streptomyces diastatochromogenes T&#252;6028
09:08

From a Natural Product to Its Biosynthetic Gene Cluster: A Demonstration Using Polyketomycin from Streptomyces diastatochromogenes Tü6028

Published on: January 13, 2017

18.4K
The Logic, Experimental Steps, and Potential of Heterologous Natural Product Biosynthesis Featuring the Complex Antibiotic Erythromycin A Produced Through E. coli
10:41

The Logic, Experimental Steps, and Potential of Heterologous Natural Product Biosynthesis Featuring the Complex Antibiotic Erythromycin A Produced Through E. coli

Published on: January 13, 2013

18.0K

Related Experiment Videos

Last Updated: May 6, 2026

Synthesis of Masarimycin, a Small Molecule Inhibitor of Gram-Positive Bacterial Growth
09:10

Synthesis of Masarimycin, a Small Molecule Inhibitor of Gram-Positive Bacterial Growth

Published on: January 7, 2022

1.8K
From a Natural Product to Its Biosynthetic Gene Cluster: A Demonstration Using Polyketomycin from Streptomyces diastatochromogenes T&#252;6028
09:08

From a Natural Product to Its Biosynthetic Gene Cluster: A Demonstration Using Polyketomycin from Streptomyces diastatochromogenes Tü6028

Published on: January 13, 2017

18.4K
The Logic, Experimental Steps, and Potential of Heterologous Natural Product Biosynthesis Featuring the Complex Antibiotic Erythromycin A Produced Through E. coli
10:41

The Logic, Experimental Steps, and Potential of Heterologous Natural Product Biosynthesis Featuring the Complex Antibiotic Erythromycin A Produced Through E. coli

Published on: January 13, 2013

18.0K

Area of Science:

  • Microbiology
  • Medicinal Chemistry
  • Biochemistry

Background:

  • Glycopeptides like vancomycin are vital for treating Gram-positive bacterial infections.
  • The declining antibiotic pipeline and rising resistance necessitate novel antimicrobial strategies.
  • Emerging resistance in enterococci and other bacteria poses a significant clinical challenge.

Purpose of the Study:

  • To review recent advancements in glycopeptide antibiotic biosynthesis.
  • To explore the mechanisms of glycopeptide resistance in bacteria.
  • To highlight the potential for developing next-generation antimicrobials based on biosynthesis knowledge.

Main Methods:

  • Review of current scientific literature on glycopeptide biosynthesis.
  • Analysis of mechanisms involving nonribosomal peptide synthetases.
  • Examination of enzymes responsible for amino acid modification and crosslinking.

Main Results:

  • Glycopeptide complexity arises from nonribosomal peptide assembly and extensive enzymatic tailoring.
  • Understanding these intricate biosynthetic pathways offers targets for novel drug design.
  • Insights into resistance mechanisms are crucial for overcoming treatment limitations.

Conclusions:

  • Recent advances in understanding glycopeptide biosynthesis and resistance are critical.
  • This knowledge can guide the development of new antibiotics to combat resistant bacteria.
  • Targeting bacterial cell wall synthesis remains a promising strategy for antimicrobial therapies.